Problem:
Sometimes, research with new pharmaceutical products may be risky to human subjects. It's big business - look what Viagra did for Pfizer stock. And, as patents expire, companies need new designer drugs to maintain profit margins. What tradeoffs do you see between full disclosure of all research risks and preventing potential subject bias? What other ethical considerations can you identify when working with human subjects?